Saturday, December 29, 2012
A working group mandated by the FDA Safety and Innovation Act to outline, in the coming months, best practices for communicating drug labeling information to blind or visually impaired patients will hold its first meeting next month.
Source found here (subscription required)
No comments:
Post a Comment